Servikal Spinal Korddaki MS lezyonları için T1 Ağırlıklı PSIR
Transkript
Servikal Spinal Korddaki MS lezyonları için T1 Ağırlıklı PSIR
Onkoloji Özel Sayısı Neurol Sci 2001; 22:S98-S102. 6 Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria. ANN NEUROL 2011; 69-292-302. 7 Zivadinov R, Bakshi R. Role of Magnetic Resonance Imaging in the Diagnosis and Prognosis of Multiple Sclerosis. From: Current Clinical Neurology: Multiple Sclerosis. Edited by: Olek MJ. Humana Press Inc., Totowa, NJ 2005. 8 Sahraian MA, Radue E-W. MS lesions in T2-weighted images. MRI Atlas of MS lesions. 2008, Springer. 9 Javalkar V, Manix M, Wilson J, Nanda A. Open ring enhancement in atypical brain demyelination. J Clin Neurosci. 2012; 19(6):910-2. doi: 10.1016/j. jocn.2011.06.037. 10 Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, Galetta SL, Hutchinson M, Johnson RT, Kappos L, Kira J, Lublin FD McFarland HF, Montalban X, Panitch H, Richert JR, Reingold SC, Polman CH. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008; 14(9): 1157-1174. doi: 10.1177/1352458508096878. 11 Yacoub HA, Al-Qudahl ZA, Lee H-J, Baisre A, Souayah N. Tumefactive Multiple Sclerosis presenting as Acute Ischemic Stroke. Journal of Vascular and Interventional Neurology 2011; 4(2): 21-23. 12 Granberg T, Martola J, KristoffersenWiberg M, Aspelin P, Fredrikson S. Radiologically isolated syndrome - incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review. MSJ 2012; 19(3) 271-280; doi: 10.1177/1352458512451943. 13 De Stefano N, Siva A. The radiologically isolated syndrome dilemma: just an incidental radiological finding or presymptomatic multiple sclerosis? MSJ 2012; 19(3) 257-258; doi: 10.1177/1352458512460418. 14 Kira J, Haller S, Kesselring J, Sahraian MA. Differential Diagnosis of Multiple Sclerosis. In Sahraian MA, Radue EW. MRI Atlas of MS lesions. 2008, Springer. 15 Lee D-H, Laemmer A, Waschbisch A, Struffert T, Maihöfner C, Schwab S, Linker RA. Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report. Journal of medical Case Report 2014, 8:155. doi: 10.1186/1752-1947-8-155. 16 Marcus JF, Waubant EL. Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis. The Neurohospitalist 2013; 3(2) 65-80. doi: 10.1177/1941874412457183. 17 Ciccarelli O. Do cortical lesions help us to distinguish MS from NMO? Neurology 2012; 79;630-1631. doi: 10.1212/ WNL.0b013e31826e9bbf. 18 Brinar VV, Habek M. Rare infections mimicking MS. Clin Neurol Neurosurg. 2010; 112(7):625-8. doi: 10.1016/j. clineuro.2010.04.011. 19 Engeholm M, Leo-Kottler B, Rempp H, Lindig T, Lerche H, Kleffner I, Henes M, Dihné M. Encephalopathic Susac’s Syndrome associated with livedo racemosa in a young woman before the completion of family planning. BMC Neurology 2013, 13:185. 20 Bentley P, Wang T, Malik O, Nicholas R, Ban M, Sawcer S, Sharma P. CADASIL with cord involvement associated with a novel and atypical NOTCH3 mutation. J Neurol Neurosurg Psychiatry 2011; 82:855-860. doi: 10.1136/jnnp.2010.223297. 21 Bastianello S, Pichiecchio A, Spadaro M, Bergamaschi R, Bramanti P, Colonnese C, Sabatini U, Uggetti C, Luccichenti G. Atypical multiple sclerosis: MRI findings and differential diagnosis. Neurol Sci 2004; 25:S356-S360. doi: 10.1007/ s10072-004-0340-2 Servikal Spinal Korddaki MS lezyonları için T1 Ağırlıklı PSIR T1 ağırlıklı PSIR, servikal spinal korddaki MS lezyonlarının ortaya çıkarılmasında büyük potansiyele sahip bulunuyor. • 3T MAGNETOM Skyra protokolünü, • 3T and 1.5T Phoenix görüntülerini • Bart Schraa’nın, “Servikal Spinal Kordda Multipl Skleroz Lezyonlarının Görüntülenmesinde T1 Ağırlıklı Faza Duyarlı İnversiyon Kazanımı” konulu makalesini indirmek için: www.siemens.com/magnetom-world İnovasyon | Mayıs 2015 | www.siemens.com.tr/inovasyon 57
Benzer belgeler
Multipl Skleroz: İmmunsüpresif Tedaviler
sonucunda mitoksantron alanlarda atakların sıklığı ve şiddetinde % 66 oranında
azalma gözlenmiştir (p<0.001) Yine tedavi alanlarda klinik progresyon anlamlı
derecede daha az gözlenmiş, MR’ da da ye...